Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 75Years
All Genders
NCT07126873

A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

Led by EndoCell Therapeutics, Inc. · Updated on 2025-08-22

21

Participants Needed

1

Research Sites

229 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will evaluate the safety, tolerability and efficacy of E-islet 01 in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia

CONDITIONS

Official Title

A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical history of Type 1 Diabetes with > 5 years of duration
  • 2-hour C-peptide level <0.3 ng/mL after a mixed meal stimulation test
  • Under continuous insulin therapy
  • At least one episode of documented severe hypoglycemia in the past 12 months or unaware hypoglycemia evaluated by Clarke scoring
  • Willing and able to conduct self-blood glucose monitoring with good compliance
  • Voluntarily agree to participate and sign informed consent
Not Eligible

You will not qualify if you...

  • Uncontrolled systemic infections including pulmonary tuberculosis, active hepatitis, positive hepatitis B surface antigen, hepatitis C virus antibody, HIV antibody, or Treponema pallidum antibody
  • History of cancer within the past 5 years or currently receiving antitumor treatment
  • Participation in other clinical trials within the past 3 months or islet cell, organ transplant, or cell therapy within past 12 months
  • Any condition judged by the investigator as unsuitable for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shanghai Changzheng Hospital

Shanghai, Shanghai Municipality, China

Actively Recruiting

Loading map...

Research Team

Y

yanyan ma

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes | DecenTrialz